Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Director's Dealing 2016

Oct 3, 2016

65830_rns_2016-10-03_c98d11d0-8b6b-4be8-8cbe-8f9008b2cd21.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHARMAXIS LTD ABN 75 082 811 630

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Dire ctor Gary Jonathan Phillips
Date of last n otice 20 November 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct or indirect interest Direct Direct Direct Direct Direct Direct Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Direct and Indirect
stered oder)ails of the circumstances giving rise to the relevant
Date of chang e 27 to 29 Se tember 201 6
No. of securities held prior to change Ordinary shares: 1,865,000Options over ordinary shares: 1,626,000
Class Ordinary sharesOptions over ordinary shares
Number acquired Direct:Ordinary shares acquired on exercise ofemployee options: 815,000Indirect:Ordinary shares acquired by HealthcareManagement Consulting Pty Ltd as trusteefor the Gary Phillips Family Trust (a relatedparty of which Mr Phillips is a beneficiary):2,280,000
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed Direct:Exercise of employee options: 815,000Ordinary shares sold on market: 400,000Ordinary shares sold to the Gary PhillipsFamily Trust: 2,280,000
Value/ConsiderationNote: If consideration is non‐cash, provide details and estimatedvaluation Exercise of employee options: NilOrdinary shares sold on market: $110,636Ordinary shares sold to Gary Phillips FamilyTrust: $621,072
No. of securities held after change Direct:Ordinary shares: NilOptions over ordinary shares: 811,000Indirect:Ordinary shares: 2,280,000
Nature of changeExample: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy‐back 1. Exercise of employee options2. On-market sale of ordinary shares topartially fund the tax liability arisingfromthevestingofemployeeoptions.3. Off-markettransferofordinaryshares to related entity

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non‐cash, provide detailsand an estimated valuation
Interest after change
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3